Pacira BioSciences, Inc. (PCRX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.46B
Last updated: Nov 17, 2026 at 3:04 AM ET
Pacira BioSciences, Inc. (PCRX) Stock Chart
Pacira BioSciences (PCRX) has a latest price of $36.48 on Nov 17, 2026, 0.5% below its 52-week high of $36.67. Its price rose 54.4% over the past 12 months. The month-end price rose 14.4% over the 10 years through Oct 2026, a compound annual rate of 1.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $76.32 in Mar 2022 and its lowest $15.05 in Sep 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PCRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PCRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 52.0%, and over 6 months it rose 62.6%. The month-end price rose 28.8% over the 3 years through Oct 2026, a compound annual rate of 8.8%.
| Period | Change |
|---|---|
| 1 month | +0.4% |
| 3 months | +52.0% |
| 6 months | +62.6% |
| 12 months | +54.4% |
| 12 months, with dividends | +54.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +28.8% | +8.8% |
| 5 years | -30.4% | -7.0% |
| 10 years | +14.4% | +1.4% |
Price by Year
Its best calendar year was 2017, when the price rose 41.3%, and its weakest was 2024, when it fell 44.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $36.39 | +40.6% |
| 2025 | $25.88 | +37.4% |
| 2024 | $18.84 | -44.2% |
| 2023 | $33.74 | -12.6% |
| 2022 | $38.61 | -35.8% |
| 2021 | $60.17 | +0.6% |
| 2020 | $59.84 | +32.1% |
| 2019 | $45.30 | +5.3% |
| 2018 | $43.02 | -5.8% |
| 2017 | $45.65 | +41.3% |
Trading Range
The price is 16.2% above its 50-day average of $31.39 and 41.8% above its 200-day average of $25.73.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $36.48 | |
| 52-week high | $36.67 | -0.5% |
| 52-week low | $18.80 | +94.0% |
| 50-day average | $31.39 | +16.2% |
| 200-day average | $25.73 | +41.8% |
Price Risk
Over 3 years, its largest fall from a peak was 67.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.06 |
| Largest fall, 1 year | -28.2% |
| Largest fall, 3 years | -67.0% |
Valuation
Pacira BioSciences traded at 10.9x earnings at the end of 2025, against a 5-year median of 10.9x and a 10-year median of 20.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PCRX
What is PCRX's 1-year price change?
Pacira BioSciences's price rose 54.4% over the past 12 months. With dividends included, the 12-month total return was 54.4%.
What is PCRX's 5-year price change?
Pacira BioSciences's month-end price fell 30.4% over the 5 years through Oct 2026, a compound annual decline of 7.0%. These figures leave out dividends.
What is PCRX's 52-week high and low?
Pacira BioSciences's 52-week high is $36.67 and its 52-week low is $18.80. Its latest price of $36.48 on Nov 17, 2026 is 0.5% below the high.
What is PCRX's beta?
Pacira BioSciences's 1-year beta against the S&P 500 is 0.06, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 28.2%.
Is the PCRX chart free?
Yes. Advanced Charting for PCRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PCRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors